Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (+2.86%)
Close on Nov 18, 2026Market cap $6.61MP/E –Yield –
Theriva Biologics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Theriva Biologics's price to sales ratio was 9.1× on Apr 29, 2011.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2011 | Apr 29, 2011 | 9.1× | – |
See a number that looks wrong?